Servier Exercises Option to Cortex's AMPAKINE(R) CX1632, An Innovative …

IRVINE, Calif., Oct 06, 2011 (BUSINESS WIRE) — Cortex Pharmaceuticals, Inc. (OTCBB (CORX)) has received written notification from Servier of its decision to exercise its option to obtain all the remaining rights to the jointly discovered high impact …
See all stories on this topic »